Charles River Laboratories | Bienes

Assets Cambio Fecha
Agilent USD 10.95B 185M 2023-12
Align Technology USD 6.08B 234.67M 2023-12
Bio-Rad Laboratories USD 12.3B 403.13M 2023-12
Bruker USD 4.24B 419.2M 2023-12
Cardinal Health USD 46.57B 2.86B 2023-12
Catalent USD 9.99B 35M 2023-12
Charles River Laboratories USD 8.2B 587.99M 2023-12
Cigna USD 149.65B 409M 2023-09
Concord Medical Services Hldg CNY 6.07B 65.14M 2023-06
CVS Health USD 249.73B 1.58B 2023-12
Danaher USD 84.49B 3.25B 2023-12
Dentsply International USD 7.37B 169M 2023-12
Galapagos EUR 4.45B 71M 2023-09
Hologic USD 8.47B 669.8M 2023-12
Humana USD 47.07B 8.84B 2023-12
Illumina USD 10.11B 11M 2023-12
Incyte USD 6.78B 393.87M 2023-12
Intrexon USD 190.69M 16.84M 2023-09
IQVIA Holdings USD 26.68B 704M 2023-12
Laboratory Of America USD 16.73B 160.9M 2023-12
Lonza CHF 17.67B 316M 2023-06
McKesson USD 66.09B 2B 2023-09
Merck EUR 49.91B 1.12B 2023-09
Mettler Toledo International USD 3.36B 66.82M 2023-12
Pfizer USD 215.02B 5.15B 2023-09
Quest Diagnostics USD 14.02B 540M 2023-12
Revvity USD 13.56B 143.12M 2023-12
Thermo Fisher Scientific USD 98.73B 1.67B 2023-12
United Therapeutics USD 7.17B 143.4M 2023-12
Veradigm USD 1.69B 23.56M 2022-09
Walgreens Boots Alliance USD 97.82B 1.2B 2023-09
Waters USD 4.5B 51.02M 2023-09
West Pharmaceutical Services USD 3.75B 85.1M 2023-09



Charles River Laboratories Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.